Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Regina Vögeli-Lange has worked on the following 69 EPO patent applications which have been published in the last five years:

EP12711093

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, A61P 17/00, A61P 19/00, A61P 29/00, A61P 37/00, C07D 487/04, C07F 9/11
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP12710852

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, A61P 17/00, A61P 19/00, A61P 29/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP12710850

PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, A61P 17/00, A61P 19/00, A61P 29/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP12775886

SELECTIVE NR2B ANTAGONISTS

IPC classification:
A61K 31/4709, A61P 25/00, C07D 271/113, C07D 401/12, C07D 403/08, C07D 413/06, C07D 413/08, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP12783457

A COMPOUND FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/55, A61P 31/14, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12809969

CO-PROCESSING METHOD AND FORMULATION FOR HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND EXCIPIENTS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13700828

HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/4427, A61K 31/443, A61K 31/4439, A61K 31/4709, A61K 31/498, A61K 31/5025, A61K 31/517, A61P 29/00, C07D 413/04, C07D 413/14, C07D 417/04, C07D 417/14, C07D 471/04, C07D 471/10, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13700833

THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 29/00, C07D 417/04, C07D 417/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700829

TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4439, A61K 31/444, A61K 31/4545, A61K 31/496, A61K 31/497, A61K 31/498, A61K 31/5025, A61K 31/506, C07D 413/04, C07D 413/14, C07D 417/04, C07D 417/14, C07D 471/04, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13701178

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/4178, A61K 45/06, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13704340

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, A61P 31/12, C07D 251/52, C07D 401/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704338

NOVEL COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/4178, A61K 31/506, A61P 31/14, C07D 405/04, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13705076

METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND

IPC classification:
C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13707493

C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/575, A61K 31/58, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13705712

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4375, A61P 31/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13706896

PROCESS FOR RESOLVING CYCLOPROPYL DIESTERS

IPC classification:
C12P 41/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13708603

N- (5S, 6S, 9R) - 5 -AMINO- 6 - (2, 3 - DIFLUOROPHENYL) -6, 7, 8, 9 - TETRAHYDRO - 5H - CYCLOHEPTA [B]PYRIDIN-9 -YL- 4 - (2 - OXO-2, 3 - DIHYDRO - 1H- IMIDAZO [4, 5 -B]PYRIDIN - 1 - YL) PIPERIDINE - 1 - CARBOXYLATE, HEMISULFATE SALT

IPC classification:
A61K 31/437, A61P 11/00, A61P 25/00, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13710940

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13710203

ARYL ETHER-BASE KINASE INHIBITORS

IPC classification:
A61K 31/444, A61P 25/00, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13713039

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
A61K 31/4745, A61P 25/00, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13714178

BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/343, A61P 31/14, C07D 307/84, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13722217

SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

IPC classification:
A61K 9/48, A61K 31/4709, A61P 31/14
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13722251

ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE

IPC classification:
A61K 9/20, A61K 31/4709, A61P 31/14
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13722947

C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/56, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13725545

SULFILIMINE AND SULPHOXIDE METHODS FOR PRODUCING FESTINAVIR

IPC classification:
C07D 307/20, C07D 309/10, C07D 407/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13739922

IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS

IPC classification:
A61K 31/53, A61P 17/08, A61P 19/02, A61P 35/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13740485

NOVEL METHODS AND INTERMEDIATES FOR THE PREPARATION OF (4BS,5AR)-12-CYCLOHEXYL-N-(N,N-DIMETHYLSULFAMOYL)-3-METHOXY-5A-((1 R,5S) -3-METHYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBONYL)-4B,5,5A,6-TETRAHYDROBENZO [3,4]CYCLOPROPA[5,6]AZEPINO[1,2-A]INDOLE-9-CARBOXAMIDE

IPC classification:
A61K 31/55, A61P 31/14, C07D 487/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13747625

DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/439, A61P 7/00, C07D 401/04, C07D 471/08, C07D 487/08, C07D 487/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13744927

ARYL LACTAM KINASE INHIBITORS

IPC classification:
A61K 31/4375, A61P 25/02, A61P 25/16, A61P 25/28, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13747624

DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/439, A61P 7/00, C07D 401/04, C07D 471/08, C07D 487/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13750479

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/16, C07D 498/16
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13762679

IMIDAZOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES

IPC classification:
A61K 31/5025, A61P 35/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13748452

PIPERIDINE AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61P 31/18, C07D 401/06, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13753225

TRICYCLIC AMIDINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/551, A61K 31/553, A61P 31/18, C07D 403/12, C07D 413/12, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13748451

TRICYCLIC ALKENE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61K 31/4545, A61P 31/18, C07D 401/06, C07D 401/14, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770806

BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AS NOTCH INHIBITORS

IPC classification:
A61K 31/55, C07D 243/18, C07D 243/26, C07D 401/04, C07F 9/38
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770811

FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS

IPC classification:
A61K 31/5513, A61P 35/00, C07D 243/24, C07D 401/04, C07D 401/12, C07D 413/12, C07D 413/14, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770809

TRICYCLIC HETEROCYCLIC COMPOUNDS AS NOTCH INHIBITORS

IPC classification:
A61K 31/55, C07D 487/04, C07D 498/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13770803

SUBSTITUTED 1,5-BENZODIAZEPINONE COMPOUNDS

IPC classification:
A61K 31/5513, A61P 35/00, C07D 243/24, C07D 401/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13783174

GUANIDINE SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/4725, A61K 31/4743, A61K 31/4745, A61K 31/496, A61P 7/02, C07D 217/26, C07D 401/06, C07D 401/14, C07D 495/04, C07D 513/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13780287

CRYSTALLINE FORMS OF A FACTOR XIA INHIBITOR

IPC classification:
A61K 31/496, A61P 7/02, C07D 401/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP12781012

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/4178, A61P 31/14, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13789457

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/12, A61P 31/22, C07D 487/04, C07D 487/12, C07K 5/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13789670

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, A61P 31/14, C07K 5/083
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13789680

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, A61P 31/14, C07K 5/08, C07K 5/083
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP13789672

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/06, A61P 31/14, C07K 5/083
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP13785706

COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
C07D 498/08, C07D 498/12, C07D 498/22
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13783188

TETRAHYDROIMDIDAZOPYRAZINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4985, A61P 11/06, A61P 25/06, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13818937

NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 / INHIBITORS

IPC classification:
A61K 31/5025, A61P 25/00, A61P 35/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP12806857

4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

IPC classification:
A61P 25/28, C07D 417/04, C07D 417/10, C07D 417/12, C07D 417/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP13818939

PYRAZOLE SUBSTITUTED IMIDAZOPYRAZINES AS CASEIN KINASE 1 D/E INHIBITORS

IPC classification:
A61K 31/5025, A61P 25/00, A61P 37/00, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14701637

MACROCYCLIC BENZOFURAN AND AZABENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/34, C07D 491/04, C07D 498/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14704444

AMMONIUM DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, A61P 31/14, C07D 251/52
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14704024

GUANIDINE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/53, A61P 31/14, C07D 251/52, C07D 403/12, C07D 403/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14706201

5H-CHROMENO[3,4-C]PYRIDINES AS INHIBITORS OF ADAPTOR ASSOCIATED KINASE 1 (AAK1)

IPC classification:
A61K 31/4375, A61P 25/02, A61P 25/16, A61P 25/18, A61P 25/28, C07D 491/052
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14712831

PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS

IPC classification:
A61K 31/415, A61K 31/4155, A61P 9/00, A61P 11/00, A61P 29/00, C07D 231/12, C07D 401/12, C07D 403/12, C07D 409/12, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14710732

PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS

IPC classification:
A61K 31/415, A61P 9/00, A61P 29/00, A61P 37/00, C07D 217/12, C07D 231/12, C07D 401/12, C07D 403/12, C07D 405/12, C07D 513/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14715470

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 38/00, A61P 31/14, C07K 5/10, C07K 5/103
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14727649

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS

IPC classification:
A61K 38/12, C07K 7/08, C07K 7/56, G01N 33/68
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14741757

TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS

IPC classification:
A61K 31/519, A61P 9/00, A61P 11/00, C07D 471/04, C07D 498/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13740435

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/4164, A61K 31/4178, A61K 45/06, A61P 31/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14745008

ARYL AMIDE KINASE INHIBITORS

IPC classification:
A61K 31/422, C07D 213/16, C07D 213/61, C07D 213/62, C07D 213/72, C07D 231/12, C07D 233/54, C07D 237/08, C07D 249/06, C07D 263/30, C07D 277/20, C07D 285/08, C07D 413/12, C07D 417/12, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14748036

COMBINATIONS COMPRISING TRICYCLOHEXADECAHEXAENE DERIVATIVES FOR USE IN THE TREATMENT OF HEPATITIS C VIRUS

IPC classification:
A61K 31/4164, A61K 31/4178, A61K 31/4184, A61P 31/14, C07D 235/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14747245

COMBINATIONS COMPRISING BIPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF HCV

IPC classification:
A61K 31/4164, A61K 31/4178, A61K 31/421, A61K 31/496, A61K 31/5377, A61P 31/14, C07D 233/00, C07D 261/02, C07D 295/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP15183086

PROCESS FOR SYNTHESIZING SUBSTITUTED ISOQUINOLINES

IPC classification:
C07D 217/24
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP14755304

IMIDAZOPYRIDAZINE KINASE INHIBITORS USEFUL TO TREATING A DISEASE OR DISORDER MEDIATED BY AAK1, SUCH AS ALZHEIMER'S DISEASE, BIPOLAR DISORDER, PAIN, SCHIZOPHRENIA

IPC classification:
A61K 31/00, A61K 31/5025, A61P 25/04, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14786421

HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT

IPC classification:
A61K 9/24
Applicant:
Bristol-Myers Squibb Holdings Ireland
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
EXAMINATION IN PROGRESS
EP14792665

PYRROLOTRIAZINE KINASE INHIBITORS

IPC classification:
A61K 31/53, A61P 25/00, A61P 25/02, A61P 25/18, A61P 25/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP12704954

COMPOUNDS FOR THE REDUCTION OF ss-AMYLOID PRODUCTION

IPC classification:
A61K 31/517, A61K 31/519, A61P 25/28, C07D 239/70, C07D 401/04, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED

Please Sign in to use this feature